Effect of variations in backfill on dissolution for an over- encapsulated comparator product

Pharmaceutical Engineering

Volumn 19, Issue 3, 1999, Pages 48-54

  Faust, Mary Beth ^a,b,c,d  

^a Clin Mfg Dept Parke Davis Res D   (United States)

^b Consum Prod R D Proc Eng C ^*  (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; LACTOSE; MICROCRYSTALLINE CELLULOSE;

ANALYTIC METHOD; ARTICLE; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG SOLUBILITY; MARKETING; PHARMACEUTICAL ENGINEERING; STANDARD;

EID: 0032984053     PISSN: 02738139     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Carney, Charles F., Michael J. Killeen, and William M. Schulteis, "Comparator Drugs for Clinical Trials," Pharmaceutical Engineering, March/April 1997, pp. 48-56.
2. "Guidance for Industry - Dissolution Testing of Immediate Release Solid Oral Dosage Forms", U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), August 1997.
3. rd Edition. Medical Economics Company, Inc. Montvale, New Jersey. 1999.
4. Handbook of Pharmaceutical Excipients, Second Edition. Edited by Ainley Wade and Paul J. Weller. American Pharmaceutical Association, Washington. 1994.